Life sciences travel programs operate under a unique set of pressures. In addition to cost control and traveler experience, programs must navigate healthcare compliance frameworks (such as PhRMA, EFPIA, and Sunshine Act reporting), heightened scrutiny around interactions with healthcare professionals (HCPs), and growing expectations for transparency and audit readiness.
As a result, friction in travel workflows doesn’t just slow operations; it can introduce compliance risk and reputational exposure. These challenges are especially visible in guest travel, global program consistency, and booking accuracy at scale. Across the industry, leading life sciences organizations are shifting their focus from simply managing travel to designing travel experiences that are easier to navigate, easier to monitor, and easier to scale.
Guest travel is the real compliance stress test
Guest travel has long been one of the most complex areas of life sciences travel programs. Healthcare professionals (HCPs), patients, and advocacy participants don’t follow traditional corporate travel models, yet their travel is often tied directly to clinical, educational, or regulatory critical activities.
Our recent benchmarking analysis of 15 global life sciences travel policies found that fewer than half consistently applied a single global standard for HCP or guest travel. In many cases, HCP guidance is embedded within broader employee travel rules or split across multiple compliance documents, creating fragmented experiences for both travelers and planners.
More integrated technology ecosystems are helping organizations close gaps. By connecting invitation, registration, booking, and post-trip reporting into a single, compliant workflow, travel and meetings teams can reduce manual handoffs while maintaining visibility into policy adherence and spend. Integrated meetings and guest travel platforms—combined with compliant online booking access for approved planners—enable a more modern, consumer-grade experience without sacrificing control.
For HCPs and patients, this means fewer barriers to booking, clearer communication, and real-time support throughout the journey. For organizations, it creates a more transparent and defensible environment for managing highly visible travel activity.
Global consistency is harder than it looks
As life sciences travel programs expand globally, service delivery can quickly become fragmented. Differences in regional processes, regulatory requirements, and service models introduce operational strain and increase risk.
Many organizations are responding by adopting globally aligned service models designed specifically for life sciences complexity. These models centralize core elements—such as technology, reporting, billing, and compliance frameworks—while preserving localized service delivery and regional expertise.
Benchmarking data underscores the challenge of this balance. While most of the 15 policies analyzed defined global travel standards in principle, fewer than two thirds clearly addressed how local or regional policies should align, or how conflicts between global and local requirements should be resolved. The result is often localized workarounds, inconsistent reporting structures, and delayed financial reconciliation.
One large life sciences organization addressed multi-market reconciliation challenges by partnering with BCD to implement a single, globally aligned reporting structure through BCD’s spend management. Standardized data fields replaced fragmented local reports, improving visibility and streamlining reconciliation across 23 countries, regardless of back-office configuration.
This type of global alignment strengthens governance and audit readiness, delivers more consistent traveler experiences across regions, and creates more predictable outcomes for global programs. For travelers, it means consistent support wherever they go. For program leaders, it reinforces confidence that global standards are being met.
Using AI to improve bookings and reduce risk
In life sciences travel, accuracy matters as much as speed. Booking errors can create downstream compliance issues and operational rework.
Targeted applications of artificial intelligence help organizations improve booking accuracy at scale. AI-enabled decision support can surface policy-aligned options, flag out-of-policy selections in real time, and reduce manual intervention, particularly for complex scenarios like HCP travel or multi-country congress attendance.
When applied responsibly, AI acts as a compliance enabler rather than a risk. For travelers, it delivers clearer, more relevant booking choices. For organizations, it supports consistency and compliance without adding operational burden.
Sustainability and travel alternatives: An emerging maturity gap
Another area where friction and maturity gaps are emerging is sustainability within the travel program. While sustainability is frequently cited as a strategic priority, benchmarking shows that explicit guidance, such as rail over air, premium economy as an alternative, or clear carbon impact visibility at point of booking , remains inconsistent across life sciences travel policies.
Sustainability doesn’t need to add complexity or risk. When sustainability is embedded directly into managed travel rather than layered on afterwards it becomes easier to govern, easier to report on, and easier for travelers to navigate. Emissions visibility and guidance at the point of sale can help support informed choices while maintaining policy compliance, audit readiness, and global consistency.
When travel works, trust follows
Together, these shifts reflect a broader evolution in how travel supports life sciences organizations. Travel programs are increasingly tied to experience, compliance, and brand reputation.
When travel works well, it strengthens trust across the ecosystem:
- With HCPs, who expect professionalism and efficiency
- With patients, who need clarity, care, and reliability
- With regulators, who require transparency and control
As life sciences travel programs continue to evolve, organizations that prioritize simplicity, visibility, and intelligent automation will be better positioned to support both business outcomes and the communities they serve. If you’d like to explore how these approaches could support your program, the BCD Life Sciences team is ready to help.
When travel works, everyone benefits; from HCPs and patients to compliance teams and regulators. Designing a travel program that is easy for travelers to navigate while also being easy to govern isn’t just operationally smart. It’s essential for life sciences organizations today.
Susan Lyster
Vice President – Global Sales at BCD Travel